Research Papers:
Transforming growth factor β-induced epithelial to mesenchymal transition requires the Ste20-like kinase SLK independently of its catalytic activity
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1377 views | HTML 3695 views | ?
Abstract
Jillian Conway1,2, Khalid N. Al-Zahrani1,2, Benjamin R. Pryce1,2, John Abou-Hamad1,2 and Luc A. Sabourin1,2
1University of Ottawa, Department of Cellular and Molecular Medicine, Ottawa, Ontario, K1H8M5, Canada
2Ottawa Hospital Research Institute, Cancer Therapeutics, Ottawa, Ontario, K1H8L6, Canada
Correspondence to:
Luc A. Sabourin, email: [email protected]
Keywords: SLK; Stk2; EMT; TGFβ; invasion
Received: June 06, 2017 Accepted: August 26, 2017 Published: October 19, 2017
ABSTRACT
Invasion can be stimulated in vitro using the soluble ligand transforming growth factor-β (TGFβ) to induce a process called epithelial-to-mesenchymal transition (EMT) characterized by cell-cell junction breakdown and an invasive phenotype. We have previously demonstrated a role for Ste20-like kinase SLK cell migration and invasion. Here we show that SLK depletion in NMuMG mammary epithelial cells significantly impairs their TGFβ-induced migration and invasion. Immunofluorescence studies show that a fraction of SLK localizes to E-cadherin-positive adherens junction and that SLK impairs the breakdown of cell-cell contacts. We find that SLK-depleted cultures express significantly lower levels of vimentin protein as well as Snai1 and E-cadherin mRNA levels following TGF-β treatment. Surprisingly, our data show that SLK depletion does not affect the activation and nuclear translocation of Smad3. Furthermore, we show that expression of a dominant negative kinase does not impair tight junction breakdown and rescues Snai1 mRNA expression levels. Together these data suggest that SLK plays a novel role in TGFβ-induced EMT, independent of Smads, in a kinase activity-independent manner.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21928